Myasthenia gravis: understanding treatment patterns and direct medical costs in the Czech Republic
Abstract Background Myasthenia gravis (MG) is a rare autoimmune disorder with significant clinical implications, including life-threatening myasthenic crises and exacerbations. Understanding real-world treatment patterns, especially associated direct medical costs, is essential for the effective man...
Prif Awduron: | Gleb Donin, Karla Mothejlová, Magda Horáková, Stanislav Vohanka |
---|---|
Fformat: | Erthygl |
Iaith: | English |
Cyhoeddwyd: |
BMC
2024-12-01
|
Cyfres: | Orphanet Journal of Rare Diseases |
Pynciau: | |
Mynediad Ar-lein: | https://doi.org/10.1186/s13023-024-03504-3 |
Eitemau Tebyg
-
Burden of Myasthenia Gravis in the Czech Republic: Analysis of the Nationwide Patient Registry
gan: Stanislav Voháňka, et al.
Cyhoeddwyd: (2024-12-01) -
IMMUNOPATHOGENESIS OF MYASTHENIA GRAVIS (REVIEW)
gan: E. D. Gasymly
Cyhoeddwyd: (2018-06-01) -
Seronegative Maternal Ocular Myasthenia Gravis and Delayed Transient Neonatal Myasthenia Gravis
gan: Courtney Townsel, et al.
Cyhoeddwyd: (2016-03-01) -
Pregnancy with Myasthenia Gravis
gan: Ninuk Dwi ariningtyas, et al.
Cyhoeddwyd: (2020-01-01) -
Delayed diagnosis of distal myasthenia gravis: a case report
gan: M. L. Cao, et al.
Cyhoeddwyd: (2024-11-01)